Dose Adjustment Recommendation
You should reduce your testosterone cypionate dose to 60-80 mg twice weekly (total 120-160 mg/week) and recheck your testosterone level midway between injections in 6-8 weeks to target 400-700 ng/dL.
Rationale for Dose Reduction
Your current testosterone level of 1281 ng/dL is significantly above the therapeutic target range. The Endocrine Society guidelines explicitly state that for injectable testosterone enanthate or cypionate, testosterone levels should be measured midway between injections and maintained between 400-700 ng/dL 1. When testosterone exceeds 700 ng/dL, dose or frequency adjustment is required 1.
Your current regimen of 100 mg twice weekly (200 mg/week total) is producing supraphysiologic levels that increase your risk of:
- Erythrocytosis (hematocrit >54%) - the most common dose-dependent adverse effect requiring therapy interruption 1
- Cardiovascular complications
- Accelerated PSA elevation
- Mood fluctuations and sleep disturbance
Specific Dosing Algorithm
Step 1: Calculate your dose reduction
- Current dose: 100 mg twice weekly = 200 mg/week
- Current level: 1281 ng/dL (approximately 1.8x the upper target of 700 ng/dL)
- Proportional reduction: 200 mg ÷ 1.8 = approximately 110-120 mg/week
- Practical dosing: 60-80 mg twice weekly (120-160 mg/week total)
Step 2: Implement the new regimen
- Reduce each injection from 100 mg to 60-70 mg
- Maintain twice-weekly frequency (this provides more stable levels than weekly dosing)
- Continue same injection technique (deep intramuscular in gluteal muscle) 2
Step 3: Recheck testosterone level
- Measure testosterone midway between injections at 6-8 weeks 1
- Target range: 400-700 ng/dL
- If still >700 ng/dL: reduce by additional 10-20 mg/week
- If <400 ng/dL: increase by 10-20 mg/week
Critical Monitoring Requirements
Immediate safety check (before dose adjustment):
- Check hematocrit NOW - if >54%, stop testosterone completely until it decreases, then restart at reduced dose 1
- Evaluate for sleep apnea symptoms (snoring, daytime sleepiness, witnessed apneas)
- Check blood pressure
Ongoing monitoring schedule:
- Hematocrit at 3 months, then annually 1, 3
- PSA and digital rectal exam (if age ≥40 with baseline PSA >0.6 ng/mL) at 3-6 months 1
- Assess for mood swings, acne, fluid retention, breast tenderness at each visit 1
Why Twice-Weekly Dosing Matters
While the FDA label states 50-400 mg every 2-4 weeks 2, modern evidence strongly favors more frequent, smaller doses. The 2003 AACE guidelines note that "smaller doses and more frequent injections are better at maintaining circulating testosterone levels in the normal range" 4. Your twice-weekly schedule is appropriate and should be maintained - simply reduce the amount per injection rather than changing frequency 5.
Common Pitfall to Avoid
Do not simply extend your injection interval to every 2 weeks at 100 mg. This creates problematic peak-trough fluctuations with early supraphysiologic peaks (increasing side effect risk) and late-cycle hypogonadal symptoms 5, 6. The goal is stable mid-normal levels, not cycling between high and low 1, 3.
Documentation for Your Provider
When discussing with your clinician, document:
- Current regimen: testosterone cypionate 100 mg IM twice weekly
- Most recent level: 1281 ng/dL (specify timing relative to last injection)
- Proposed adjustment: 60-70 mg IM twice weekly
- Target range: 400-700 ng/dL midway between injections
The therapy goal is physiologic replacement with stable symptoms and acceptable safety parameters, not maximization of testosterone levels 5, 7.